USD 0.0
(-4.44%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 38.31 Thousand USD | -8.62% |
2022 | 41.92 Thousand USD | -15.33% |
2021 | 49.51 Thousand USD | 120.58% |
2020 | 22.44 Thousand USD | 0.0% |
2019 | 22.44 Thousand USD | 0.0% |
2018 | 22.44 Thousand USD | -98.39% |
2017 | 1.39 Million USD | 0.16% |
2016 | 1.39 Million USD | 6807.9% |
2015 | 20.18 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 37.5 Thousand USD | -0.63% |
2024 Q1 | 37.73 Thousand USD | -1.51% |
2023 FY | 38.31 Thousand USD | -8.62% |
2023 Q4 | 38.31 Thousand USD | -1.48% |
2023 Q1 | 40.68 Thousand USD | -2.98% |
2023 Q2 | 39.75 Thousand USD | -2.27% |
2023 Q3 | 38.89 Thousand USD | -2.17% |
2022 Q1 | 47.22 Thousand USD | -4.63% |
2022 FY | 41.92 Thousand USD | -15.33% |
2022 Q4 | 41.92 Thousand USD | -2.92% |
2022 Q2 | 45.03 Thousand USD | -4.63% |
2022 Q3 | 43.18 Thousand USD | -4.11% |
2021 Q2 | 57.44 Thousand USD | 155.91% |
2021 FY | 49.51 Thousand USD | 120.58% |
2021 Q1 | 22.44 Thousand USD | 0.0% |
2021 Q4 | 49.51 Thousand USD | -15.58% |
2021 Q3 | 58.66 Thousand USD | 2.11% |
2020 FY | 22.44 Thousand USD | 0.0% |
2019 FY | 22.44 Thousand USD | 0.0% |
2018 FY | 22.44 Thousand USD | -98.39% |
2017 FY | 1.39 Million USD | 0.16% |
2016 FY | 1.39 Million USD | 6807.9% |
2015 FY | 20.18 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
American Bio Medica Corporation | 379 Thousand USD | 89.89% |
Arrayit Corporation | 464.19 Thousand USD | 91.746% |
Atlantic International Corp. | - USD | -Infinity% |
Biocept, Inc. | 757 Thousand USD | 94.938% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | -2385.00 USD | 1706.541% |
DermTech, Inc. | 1 Million USD | 96.184% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 98.839% |
HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 95.786% |
IDenta Corp. | 442.28 Thousand USD | 91.337% |
Interpace Biosciences, Inc. | 1.22 Million USD | 96.877% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 163.13 Thousand USD | 76.513% |
Lumos Diagnostics Holdings Limited | 784 Thousand USD | 95.113% |
Many Bright Ideas Technologies Inc. | -375.00 USD | 10317.6% |
Medical Imaging Corp. | - USD | -Infinity% |
NovelStem International Corp. | - USD | -Infinity% |
Optigenex Inc. | 468.77 Thousand USD | 91.826% |
PharmChem, Inc. | 391.93 Thousand USD | 90.224% |
Proteome Sciences plc | 1.06 Million USD | 96.404% |
Response Genetics, Inc | 133 Thousand USD | 71.191% |
Rennova Health, Inc. | 242.64 Thousand USD | 84.209% |
RushNet, Inc. | - USD | -Infinity% |
ScreenPro Security Inc. | 73.89 Thousand USD | 48.149% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | 95.62 Thousand USD | 59.929% |
Todos Medical Ltd. | 1.02 Million USD | 96.247% |